Jessica Chubak, PhD

Chubak_Jessica__205x293.jpg

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.

Research interests and experience

 

Recent publications

Ludman EJ, McCorkle R, Bowles EA, Rutter CM, Chubak J, Tuzzio L, Jones S, Reid RJ, Penfold R, Wagner EH. Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation? Gen Hosp Psychiatry. 2015 Feb 28. pii: S0163-8343(15)00038-9. doi: 10.1016/j.genhosppsych.2015.02.008 [Epub ahead of print]. PubMed

Hubbard RA, Chubak J, Rutter CM. Estimating screening test utilization using electronic health records data. eGEMS. 2014 2(1). Article 14. doi: 10.13063/2327-9214.1109.

Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec;27(6):789-95. doi: 10.3122/jabfm.2014.06.140125. PubMed

Wang CY, Tapsoba JD, Anderson ML, Vernon SW, Chubak J, Fuller S, Green BB. Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1683-8. doi: 10.1158/1055-9965.EPI-14-0270. Epub 2014 Jun 2. PubMed

Green BB, Coronado GD. BeneFITs to increase colorectal cancer screening in priority populations. JAMA Intern Med. 2014 Aug;174(8):1242-3. doi: 10.1001/jamainternmed.2014.730. PubMed

Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N. Cancer risk awareness and concern among women with a family history of breast or ovarian cancer.  Behav Med. 2014 Jul 25:0 [Epub ahead of print]. PubMed

Murphy CC, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep;66:123-30. doi: 10.1016/j.ypmed.2014.06.013. Epub 2014 Jun 15. PubMed

 

Research

Cancer-prevention-story_1col.jpg

Improving cancer prevention and early detection

How KPWHRI is contributing to better cancer screening and better outcomes for patients.

Research

Animal-care-giver_service-dog_with-patient_1col.jpg

How did the pandemic impact hospital visits with animals?

Top pediatric oncology hospitals reported lasting changes to programs involving visits with animals.

Healthy findings blog

QA_Cancer-Harm_illustration_1col.jpg

Improving reporting of cancer screening harms

Aruna Kamineni, PhD, MPH, discusses her recent study on how guidelines report screening risks.